Results 81 to 90 of about 17,715 (228)

Identifying Knowledge Gaps among LVAD Candidates

, 2019
Education is an important aspect of evaluation and consent for left ventricular assist device (LVAD) candidates. A better understanding of candidate knowledge during the education process can help identify knowledge gaps and improve informed consent ...
J.S. Blumenthal-Barby, Kristin M. Kostick, Meredith Buchberg Trejo, Jerry D. Estep   +3 more
core   +1 more source

Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Myocardial fibrosis is prevalent in cardiomyopathies that result in heart failure with reduced ejection fraction. Heart failure with reduced ejection fraction treated with a left ventricular assist device (LVAD) yields hemodynamic unloading ...
Rachel M. Biggs, Yuhua Zhang, Daniel N. Silverman, Catalin F. Baicu, An O. Van Laer, Lauren Wakefield, Devki Bhatt, Stephanie Masline, Lily S. Neff, Arman Kilic, Lucas J. Witer, Brian A. Houston, Samuel J. Coeyman, William J. Richardson, Michael R. Zile, Amy D. Bradshaw   +15 more
doaj   +1 more source

Computational analysis of the hemodynamic characteristics under interaction influence of β-blocker and LVAD

BioMedical Engineering OnLine, 2018
Background Hemodynamic characteristics of the interaction influence among support level and model of LVAD, and coupling β-blocker has not been reported.
Kaiyun Gu, Zhe Zhang, Yu Chang, Bin Gao, Feng Wan   +4 more
doaj   +1 more source

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome

American Journal of Hematology, Volume 101, Issue 9, Page 2147-2156, September 2026.
ABSTRACT Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history of bleeding. It is frequently associated with systemic diseases, particularly lymphoproliferative disorders (LPDs) and myeloproliferative ...
Alessandro Ciavarella, Luciano Baronciani, Omid Seidizadeh, Paola Colpani, Elio Ingenito, Daniele Cattaneo, Maria Teresa Pagliari, Addolorata Truma, Alessandra Iurlo, Simona Maria Siboni, Flora Peyvandi   +10 more
wiley   +1 more source

LVAD Contact Dermatitis Supplemental

Supplemental for LVAD Contact Dermatitis Systematic ...
Wei, Brian
core   +1 more source

Update on the Pathophysiology, Aetiology and Management of Central Sleep Apnoea

Respirology, Volume 31, Issue 9, Page 873-881, September 2026.
ABSTRACT Central sleep apnoea (CSA) of the periodic breathing type occurs during the transition between wakefulness and stage 1 and 2 non‐REM sleep. In adults at sea level, it occurs most commonly due to advanced heart failure (HF) or chronic opioid use and in ~5% of obstructive sleep apnoea patients initiating CPAP.
Sahan D. Chandrasekara, Matthew T. Naughton   +1 more
wiley   +1 more source

Understanding Stroke and Cerebral Physiology in the LVAD population [PDF]

Left ventricular assist device (LVAD) therapy is one of the main surgical therapies available for end stage heart failure. Technologic advances have improved survival, but stroke remains one the main causes of both morbidity and mortality within this ...
Rao, Sriram
core   +1 more source

Recent change in bridging strategy and improved clinical outcomes following durable left ventricular assist device implantation in Japan

JHLT Open
Background: Destination therapy (DT) was approved in Japan in May 2021. Use of Impella device as a bridge to left ventricular assist device (LVAD) implantation has been increasing.
Makiko Nakamura, Teruhiko Imamura, Yoshikatsu Saiki, Minoru Ono, Koichiro Kinugawa   +4 more
doaj   +1 more source

Percutaneous versus open cannulation for mechanical support in patients with right ventricular failure after left ventricular assist device placement [PDF]

Exploration of Cardiology
Aim: Temporary right ventricular assist device (t-RVAD) is an option for those patients in right ventricular failure (RVF) after left ventricular assist device (LVAD) resistant to ionotropic therapy.
Amit Prasad, Anthony Kronfli, Nadia Assiaoui, Christoph Brehm, Behzad Soleimani   +4 more
doaj   +1 more source

Trends and In‐Hospital Outcomes of Ventricular Tachycardia in Ischemic Versus Non‐Ischemic Dilated Cardiomyopathy—An Insight From the Nationwide Readmissions Database (2016–2020)

Annals of Noninvasive Electrocardiology, Volume 31, Issue 5, September 2026.
Lower rates of sudden cardiac arrest and major adverse cardiovascular events in NIDCM patients. Higher rates of in‐hospital mortality, stroke, and heart failure‐related admissions in NIDCM patients. ABSTRACT Background Ventricular tachycardia (VT) is a major cause of morbidity and mortality in patients with structural heart disease, yet real‐world ...
Medhat Chowdhury, Sanchit Duhan, Rasheed Bahar, Mohamad Hasan Jawadi, Bijeta Keisham, Harini Lakshman, Marc Zughaib, Yasar Sattar, Christopher Bradley, Marcel Zughaib   +9 more
wiley   +1 more source